CSIMarket Company Name, Ticker, Industry, else..
 
Holdco Nuvo Group D g Ltd   (NASDAQ: NUVO)
Other Ticker:  
 
 
Price: $0.1700 $-0.05 -23.561%
Day's High: $0.22 Week Perf: -26.91 %
Day's Low: $ 0.17 30 Day Perf: -76.57 %
Volume (M): 554 52 Wk High: $ 2.04
Volume (M$): $ 94 52 Wk Avg: $1.01
Open: $0.22 52 Wk Low: $0.17



 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) -
 Employees -
 Revenues (TTM) (Millions $) 0
 Net Income (TTM) (Millions $) 0
 Cash Flow (TTM) (Millions $) -1
 Capital Exp. (TTM) (Millions $) 0

Holdco Nuvo Group D G Ltd


   Company Address: 94 Yigal Alon St. Tel Aviv 6789155 NJ
   Company Phone Number: 554-9041   Stock Exchange / Ticker: NASDAQ NUVO


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
NTRB      % 
VYST      % 
ZYXI      % 
AVDL      % 
• View Complete Report
   



Medinotec Inc

Exceptional 28.089%, improvement in revenue by Medinotec Inc over the most recent fiscal period

Due to strong revenue elevation Medical Equipment and Supplies company turned into profitability, Revenue inched up by 28.089 % to $2.57 million, earnings per share were at $0.03, in proportion to $-0.04 in the same three months a year before.

Stimcell Energetics Inc

The company published operating loss of $-0.130698 million, in the second quarter of 2025

The Medical Equipment and Supplies industry reporters begin to analyze the second quarter of 2025 earnings. Today those reporters observe operating loss of $-0.130698 million, from the company, as it hasn't stated any top-line still, for the own September to November 30 2024 quarter.

Angiodynamics Inc

A sharpe Decline -8.121 %, in revenue at ANGO in the second quarter of 2025

Lower orders led to vanishing revenue and an increased loss, in the financial period closing November 30 2024 ANGO decreased a loss per share to $-0.26 per share, while Revenue dropped by -8.121 % to $71.91 million, year on year.

Odyssey Health Inc

Odyssey Health Inc. Releases Q1 2025 Financial Results Amidst Ongoing Challengesnnnn

Investors Eye Odyssey Health Inc: Navigating Challenges Amidst Earnings ReportsnnnBy nAs the earnings cycle for fiscal August to October 31, 2024, unfolds, a number of companies from the Medical Equipment and Supplies sector have reported their financial results, providing insight into their operational performances in a challenging market. Among those is Odyssey Health Inc, which has recently raised eyebrows with its latest earnings report, reflecting a significant operating shortfall and highlighting ongoing challenges within the company.For the fiscal period ending October 31, 2024, Odyssey Health Inc reported an operating shortfall of $580,328, an improvement from the previous year's reported shortfall of $847,239. This indicates that the company is working towards more cost-effective operations, but the journey towards profitability appears fraught with difficulties. The results also revealed that the net loss has expanded to $1.019 million, suggesting that despite the operational adjustments, the company is still navigating a tough financial landscape.
Heartsciences Inc

Heartsciences Inc. Stays Steady: Q2 2025 Revenue Holds Firm Against Yearly Comparisons

For the financial time-frame closing October 31 2024 HSCS decreased a loss per share of $-2.27 per share compare to $-16.00 a year ago and EPS improved from $-2.64 per share from the preceding reporting period. The revenue remained unchanged to $0.00 million from $0.00 million in the same reporting period a year ago and sequentially from $0.00 million.










Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com